AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Surveillance for Multifocal GGNs

Recruitingn/aAges 18 Years - 75 YearsAllFudan University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a single-arm, multi-center, phase III trial conducted under the Eastern Cooperative Thoracic Oncoloy Project (ECTOP) with the identification number ECTOP-1021. The primary objective of the study is to assess the overall survival of patients with multifocal ground-glass opacities by employing a active surveillance approach rather than opting for surgical resection.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria Patients eligible for enrollment in the study are required to meet all the following criteria. 1. Demonstrates the following on thin-section computed tomography (TSCT) scan: 1. Presence of three or more GGNs (bilateral lesions are permitted). 2. All lesions have remained stable without regression or enlargement for at least 3 months. 3. The dominant lesion (the lesion with the largest maximum tumor diameter) has a maximum tumor diameter \>=0.6cm and \<=2cm. 4. CTR \<=0.25 in all lesions. 5. No lymph node with a diameter \>1cm in the mediastinal view. 6. Not adjacent to the pleura in dominant lesion and no sign of pleural retraction in any lesions. 2. Aged 18-75 years. 3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. 4. Has not previously undergo any anti-tumor drug or radiation therapy. 5. Written informed consent. Exclusion criteria Patients will be excluded if they meet any of the following criteria. 1. History of any prior malignancies within the past 5 years. 2. History of lung surgery. 3. History of interstitial pneumonia, pulmonary fibrosis or other severe pulmonary diseases. 4. Presence of severe or uncontrolled diseases that may possibly reduce the 10-year life expectancy.
๐Ÿ’Š

What it tests

  • Watchful waiting
๐Ÿ“

Where

1 site
Fudan University Cancer Center
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy